Entrada Therapeutics Inc (TRDA) Insider Trading
- $923,397.49
- $4,198,583.60
- Dec. 10, 2024
- Dipal Doshi
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Dec. 10, 2024 | Major Shareholder | 22,935 | $20.77 | Sell | $476,359.95 | |
Dec. 2, 2024 | CFO | 5,000 | $20.00 | Sell | $100,000.00 | |
Nov. 29, 2024 | CFO | 1,000 | $19.97 | Sell | $19,970.00 | |
Nov. 13, 2024 | Insider | 2,700 | $20.04 | Sell | $54,108.00 | |
Nov. 11, 2024 | CFO | 8,637 | $19.98 | Sell | $172,567.26 | |
Nov. 11, 2024 | Insider | 1,409 | $20.01 | Sell | $28,194.09 | |
Oct. 16, 2024 | Insider | 600 | $18.00 | Sell | $10,800.00 | |
Sept. 26, 2024 | COO | 847 | $16.00 | Sell | $13,552.00 | |
Sept. 9, 2024 | Insider | 2,642 | $15.09 | Sell | $39,867.78 | |
Sept. 9, 2024 | CFO | 3,195 | $14.97 | Sell | $47,829.15 | |
Sept. 9, 2024 | COO | 1,904 | $15.07 | Sell | $28,693.28 | |
Sept. 6, 2024 | Insider | 600 | $15.24 | Sell | $9,144.00 | |
Sept. 6, 2024 | COO | 399 | $15.19 | Sell | $6,060.81 | |
July 15, 2024 | Insider | 638 | $18.00 | Sell | $11,484.00 | |
July 15, 2024 | CEO | 1,600 | $17.81 | Sell | $28,496.00 | |
July 12, 2024 | Insider | 600 | $18.00 | Sell | $10,800.00 | |
July 12, 2024 | CEO | 300 | $18.00 | Sell | $5,400.00 | |
July 8, 2024 | CFO | 1,758 | $14.95 | Sell | $26,282.10 | |
June 13, 2024 | CEO | 1,000 | $16.17 | Sell | $16,170.00 | |
May 20, 2024 | Insider | 9,675 | $15.19 | Sell | $146,963.25 | |
May 16, 2024 | Insider | 1,000 | $15.00 | Sell | $15,000.00 | |
May 16, 2024 | CEO | 1,800 | $15.00 | Sell | $27,000.00 | |
May 8, 2024 | Director | 2,276 | $14.04 | Buy | $31,955.04 | |
April 8, 2024 | Director | 2,600 | $13.57 | Buy | $35,282.00 | |
March 28, 2024 | Director | 1,512 | $13.75 | Buy | $20,790.00 | |
March 25, 2024 | Director | 3,180 | $13.36 | Buy | $42,484.80 | |
March 21, 2024 | Director | 704 | $13.24 | Buy | $9,320.96 | |
March 19, 2024 | Director | 900 | $12.66 | Buy | $11,394.00 | |
Feb. 15, 2024 | CEO | 1,000 | $15.00 | Sell | $15,000.00 | |
Jan. 16, 2024 | CEO | 1,000 | $15.99 | Sell | $15,990.00 | |
Dec. 26, 2023 | CFO | 94 | $16.67 | Sell | $1,566.98 | |
Dec. 22, 2023 | CFO | 10,206 | $15.69 | Sell | $160,132.14 | |
Dec. 20, 2023 | CEO | 1,000 | $15.00 | Sell | $15,000.00 | |
Nov. 13, 2023 | CEO | 1,000 | $16.23 | Sell | $16,230.00 | |
Oct. 17, 2023 | CEO | 1,000 | $15.00 | Sell | $15,000.00 | |
Sept. 13, 2023 | CEO | 1,000 | $15.00 | Sell | $15,000.00 | |
Sept. 6, 2023 | Insider | 892 | $13.48 | Sell | $12,024.16 | |
Sept. 6, 2023 | CFO | 950 | $13.48 | Sell | $12,806.00 | |
Sept. 6, 2023 | COO | 972 | $13.47 | Sell | $13,092.84 | |
Aug. 14, 2023 | CEO | 1,000 | $15.67 | Sell | $15,670.00 | |
Aug. 4, 2023 | Insider | 6,898 | $14.14 | Sell | $97,537.72 | |
Aug. 2, 2023 | Insider | 10,348 | $15.19 | Sell | $157,186.12 | |
July 11, 2023 | CFO | 3,884 | $18.00 | Sell | $69,912.00 | |
July 10, 2023 | COO | 3,200 | $18.00 | Sell | $57,600.00 | |
July 10, 2023 | Insider | 3,026 | $18.00 | Sell | $54,468.00 | |
June 22, 2023 | COO | 7,097 | $16.02 | Sell | $113,693.94 | |
June 21, 2023 | CFO | 17,500 | $15.01 | Sell | $262,675.00 | |
June 20, 2023 | COO | 8,885 | $14.94 | Sell | $132,741.90 | |
April 27, 2023 | CEO | 2,000 | $13.71 | Sell | $27,420.00 | |
April 17, 2023 | Insider | 3,961 | $18.00 | Sell | $71,298.00 |
Insiders are both buying and selling Entrada Therapeutics Inc stock.
The insider traders at Entrada Therapeutics Inc are: Dipal Doshi, Kory James Wentworth, Nathan J Dowden, Natarajan Sethuraman, Nerissa Kreher, Peter S Kim, Bros. Advisors Lp Baker, John F Crowley, and Bioventures 2018 L.P. Mpm
The most active insider trader at Entrada Therapeutics Inc is Dipal Doshi with 32 trades.
Kory James Wentworth has sold the most Entrada Therapeutics Inc stock with a total value of $1,181,807.12.
Bros. Advisors Lp Baker has bought the most Entrada Therapeutics Inc stock with a total value of $969,149.33.
The most recent insider trade for Entrada Therapeutics Inc was on Dec. 10, 2024.
The single biggest insider buy for Entrada Therapeutics Inc was from Bros. Advisors Lp Baker with a total value of $245,528.64 on June 6, 2022.
The single biggest insider sell for Entrada Therapeutics Inc was from Bioventures 2018 L.P. Mpm with a total value of $476,359.95 on Dec. 10, 2024.